The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.

Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...

WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...

Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a CBO analysis.

An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the ...

The House and Senate are taking far different approaches to next year's appropriations, but neither chamber has fully ...

St. Paul Public Library says the Rondo location is closing early on Saturdays and staying closed on Sundays due to limited ...

The Trump administration has touted AI as a way to cut government staffing, but the FDA's new AI tool has been citing ...

Last Monday, the U.S. Department of Health and Human Services (HHS) finalized 10,000 layoffs across federal health agencies, including the National Institutes of Health (NIH), U.S. Food and Drug ...

Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...